Comparison of Blood Pressure Variability Between Losartan and Amlodipine in Essential Hypertension (COMPAS-BPV)

Jun-Won Lee1, Eunhee Choi2, Jung-Woo Son1

  • 1Division of Cardiology, Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju Severance Christian Hospital, Wonju, Republic of Korea.

Insights

Amlodipine and losartan showed similar effects on systolic blood pressure variability (BPV). However, amlodipine may be more effective in reducing overall BPV in essential hypertension patients.

Area of Science:

  • Cardiology
  • Pharmacology
  • Hypertension Management

Background:

  • Established antihypertensive therapies using renin-angiotensin system blockers and calcium channel blockers do not yet have a defined strategy for targeting blood pressure variability (BPV).
  • Essential hypertensive patients require comparative studies on the efficacy of different antihypertensive agents in managing BPV.

Purpose of the Study:

  • To compare the efficacy of losartan (a renin-angiotensin system blocker) and amlodipine (a calcium channel blocker) in reducing blood pressure variability (BPV) and systolic blood pressure (SBP).

Main Methods:

  • A randomized trial involving essential hypertensive patients assigned to either losartan 50 mg or amlodipine 5 mg.
  • Medications were uptitrated, with hydrochlorothiazide added as needed over a 6-month period.
  • Primary endpoint: office visit-to-visit standard deviation (SD) of SBP; Secondary endpoints: average real variability (ARV), office SBP, and home SBP.

Main Results:

  • The office visit-to-visit SD of SBP was comparable between the losartan and amlodipine groups.
  • The losartan group exhibited significantly higher office visit-to-visit ARV of SBP and evening day-to-day home BPV indexes.
  • While absolute SBP reduction was similar, office mean SBP at 6 months was higher in the losartan group.

Conclusions:

  • Both losartan and amlodipine demonstrated similar effects on reducing office visit-to-visit SD of SBP.
  • Amlodipine may offer superior BPV reduction compared to losartan, as indicated by higher ARV and home BPV indexes in the losartan group.
  • Amlodipine could be a preferred choice for managing BPV in essential hypertensive patients.
Abstract

Related Concept Videos

Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
2.2K
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.2K
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.1K
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.5K